Panacea Product “GenUltimate TBG” Poised for June 6, 2019 Launch Decision Diagnostics Corp (DECN) vs Johnson & Johnson (JNJ) Litigation Update
LOS ANGELES, CA - May 29, 2019 - Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year old, diabetes-focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ('Sunshine') diabetes test strip, the internationally launched GenSure! Read More. See More Information: http://www.thestreetnow.com/spotlight/dailynews/ ..
Disclaimer: I post on stocks that I own or am thinking about owning, I am not paid to post about them. If that changes you can find the disclosure in my IRP page. Do your DD, buy and sell based on that DD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.